No longer published by Taylor & Francis
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
Topics of current interest to clinical, experimental and basic scientists are published in critical subjects, such as psychopharmacology, psychiatry and behavioral science. Psychiatry and Clinical Psychopharmacology effectively bridges the gap between basic science and clinical application. Access to the Journal is available to all interested persons with no subscription fees, furthering the aim of reaching all interested national and international associations and individuals.
Psychiatry and Clinical Psychopharmacology was formerly titled
Bulletin of Clinical Psychopharmacology from the first volume in 1990 until 2016.
The standard article publishing charge (APC) for this journal is £575 / US$750 / €665. Depending on your location these charges may be subject to local taxes. Once your paper has been assessed for suitability by the editor, it will then be single blind peer-reviewed by independent, anonymous, expert referees.
![Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110802/Subject-Sample-2021-Behavioral-Sciences.jpg"})